US Stock MarketDetailed Quotes

QNRX Quoin Pharmaceuticals

Watchlist
  • 0.3084
  • -0.0226-6.84%
Close Feb 14 16:00 ET
  • 0.3080
  • -0.0004-0.12%
Post 20:01 ET
2.76MMarket Cap-0.08P/E (TTM)

About Quoin Pharmaceuticals Company

Quoin Pharmaceuticals Ltd. engages in the development of therapeutic products for the treatment of rare and orphan diseases. Its product pipeline includes QRX003, QRX004, QRX007, and QRX008. The company was founded by Michael Myers and Denise Carter on March 5, 2018 and is headquartered in Ashburn, VA.

Company Profile

SymbolQNRX
Company NameQuoin Pharmaceuticals
Listing DateJul 29, 2016
Issue Price6.50
Founded1986
CEOMr. Michael Myers
MarketNASDAQ
Employees4
Securities TypeDR
ADS Ratio1.0 : 1.0
Fiscal Year Ends12-31
Address42127 Pleasant Forest Court
CityAshburn
ProvinceVirginia
CountryUnited States of America
Zip Code20148-7349
Phone1-703-980-4182
Websitehttp://www.quoinpharma.com

Company Executives

  • Name
  • Position
  • Salary
  • Michael Myers
  • Chairman of the Board and Chief Executive Officer
  • 1.26M
  • Gordon Dunn
  • Chief Financial Officer and Principal Accounting Officer
  • 775.94K
  • Denise Carter
  • Director and Chief Operating Officer
  • 1.07M
  • Dr. Dennis H. Langer, J.D.,M.D.
  • Independent Director
  • 117.62K
  • Michael Sember
  • Independent Director
  • 107.62K
  • Natalie Leong
  • Independent Director
  • 122.62K
  • Anthony James Culverwell
  • Independent Director
  • 122.62K
  • Joseph P. Cooper
  • Independent Director
  • 112.62K

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
HENDERA
831152
+30.00%
Hengerda New Materials
300946
+20.01%
Fujian Nebula Electronics.,Ltd
300648
+20.00%
4
Cubic Digital Technology
300344
+19.98%
5
HNAC Technology
300490
+19.95%
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
Discussing
Major earnings are approaching! What's ahead for Chinese stocks in 2025?
Recently, institutions such as Goldman Sachs, Morgan Stanley, and Appaloosa LP have spoken positively about Chinese assets. 🎙️Discussion: 1 Show More
Alibaba Group Q4 FY2024 earnings conference call